In addition, according to Oncomine-based expression analysis, PHLDA1 was found to be upregulated in brain, colorectal, kidney, lymphoma, melanoma, myeloma, ovarian, and pancreatic cancer but downregulated in breast, esophageal, cervical, liver cancer, head and neck, and lymphoma cancer. Here, PHLDA1 is linked to liver cancer.